ACM
PFE icon

Argentus Capital Management’s Pfizer PFE Stock Holding History

Argentus Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,677
Closed -$632K – 348
2016
Q3 		$632K Buy
19,677
+21
+0.1% +$702 0.22% 107
2016
Q2 		$657K Sell
19,656
-8,668
-31% -$277K 0.28% 78
2016
Q1 		$797K Sell
28,324
-1,309
-4% -$37.4K 0.28% 100
2015
Q4 		$908K Sell
29,633
-105,429
-78% -$3.32M 0.28% 89
2015
Q3 		$4.03M Sell
135,062
-192,719
-59% -$6.18M 0.6% 40
2015
Q2 		$10.4M Sell
327,781
-2,268
-0.7% -$73.9K 1.59% 11
2015
Q1 		$10.9M Buy
330,049
+4,438
+1% +$141K 1.72% 10
2014
Q4 		$9.62M Buy
325,611
+45,535
+16% +$1.31M 1.61% 10
2014
Q3 		$7.86M Buy
280,076
+75,401
+37% +$2.12M 1.26% 16
2014
Q2 		$5.76M Sell
204,675
-16,008
-7% -$456K 1.51% 18
2014
Q1 		$6.72M Buy
220,683
+22,837
+12% +$681K 1.63% 10
2013
Q4 		$5.75M Buy
197,846
+5,068
+3% +$147K 1.22% 12
2013
Q3 		$5.25M Buy
192,778
+3,469
+2% +$94.4K 1.21% 13
2013
Q2 		$5.03M Buy
+189,309
New +$5.23M 1.19% 12

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Argentus Capital Management's PFE Position: Q4 2016 in Review

Argentus Capital Management sold out of Pfizer (PFE) in Q4 2016, closing a stake of 19,677 shares — an estimated $632K sold.

Argentus Capital Management first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $10.9M in Q1 2015. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • Argentus Capital Management reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
  • Argentus Capital Management sold 19,677 Pfizer shares in Q4 2016, an estimated $632K.
  • Argentus Capital Management first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
  • Argentus Capital Management's Pfizer position peaked at $10.9M in Q1 2015.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.